SGA
SYNH

Strategic Global Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Strategic Global Advisors’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-12,281
Closed -$715K – 171
2020
Q2 		$715K Buy
12,281
+1,567
+15% +$84.2K 0.15% 116
2020
Q1 		$422K Sell
10,714
-11,709
-52% -$685K 0.11% 122
2019
Q4 		$1.33M Sell
22,423
-144
-0.6% -$7.74K 0.28% 94
2019
Q3 		$1.2M Buy
+22,567
New +$1.16M 0.27% 96

Other funds holding SYNH

AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return
THLTP
Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Strategic Global Advisors's SYNH Position: Q3 2020 in Review

Strategic Global Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2020, closing a stake of 12,281 shares — an estimated $715K sold.

Strategic Global Advisors first reported a position in SYNH in Q3 2019 and held it in 4 quarters. The position peaked at $1.33M in Q4 2019. 300 funds tracked by Wall St. Rank hold SYNH as of Q3 2020.

  • Strategic Global Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2020 after selling out during the quarter.
  • Strategic Global Advisors sold 12,281 Syneos Health, Inc. Class A Common Stock shares in Q3 2020, an estimated $715K.
  • Strategic Global Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2019 and held it in 4 quarters.
  • Strategic Global Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $1.33M in Q4 2019.
  • 300 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2020.

Based on Strategic Global Advisors's 13F filing for Q3 2020, filed 13 Nov 2020.